Market Research Logo

Global Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017

Global Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Atopic Dermatitis patients study in a new report ‘Global Atopic Dermatitis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Atopic Dermatitis epidemiology, Atopic Dermatitis diagnosed patients, and Atopic Dermatitis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Atopic Dermatitis derived from epidemiological analysis, percentage of patients diagnosed with Atopic Dermatitis, and percentage of patients treated with a therapy.

The study helps executives estimate Atopic Dermatitis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Atopic Dermatitis prevalence, Atopic Dermatitis diagnosis rate, and Atopic Dermatitis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Atopic Dermatitis Patient Flow
  • Atopic Dermatitis Prevalence
  • Atopic Dermatitis Diagnosed Patients
  • Atopic Dermatitis Treated Patients


1. Atopic Dermatitis: Disease Definition
2. Global Atopic Dermatitis Patient Flow
2A. Global Atopic Dermatitis Prevalence
2B. Global Atopic Dermatitis Diagnosed Patients
2C. Global Atopic Dermatitis Treated Patients
3. Atopic Dermatitis Patient Flow in the US
3A. Atopic Dermatitis Prevalence in the US
3B. Atopic Dermatitis Diagnosed Patients in the US
3C. Atopic Dermatitis Treated Patients in the US
4. Atopic Dermatitis Patient Flow in Europe
4A. Atopic Dermatitis Prevalence in Europe
4B. Atopic Dermatitis Diagnosed Patients in Europe
4C. Atopic Dermatitis Treated Patients in Europe
5. Atopic Dermatitis Patient Flow in Germany
5A. Atopic Dermatitis Prevalence in Germany
5B. Atopic Dermatitis Diagnosed Patients in Germany
5C. Atopic Dermatitis Treated Patients in Germany
6. Atopic Dermatitis Patient Flow in France
6A. Atopic Dermatitis Prevalence in France
6B. Atopic Dermatitis Diagnosed Patients in France
6C. Atopic Dermatitis Treated Patients in France
7. Atopic Dermatitis Patient Flow in Spain
7A. Atopic Dermatitis Prevalence in Spain
7B. Atopic Dermatitis Diagnosed Patients in Spain
7C. Atopic Dermatitis Treated Patients in Spain
8. Atopic Dermatitis Patient Flow in Italy
8A. Atopic Dermatitis Prevalence in Italy
8B. Atopic Dermatitis Diagnosed Patients in Italy
8C. Atopic Dermatitis Treated Patients in Italy
9. Atopic Dermatitis Patient Flow in UK
9A. Atopic Dermatitis Prevalence in UK
9B. Atopic Dermatitis Diagnosed Patients in UK
9C. Atopic Dermatitis Treated Patients in UK
10. Atopic Dermatitis Patient Flow in Japan
10A. Atopic Dermatitis Prevalence in Japan
10B. Atopic Dermatitis Diagnosed Patients in Japan
10C. Atopic Dermatitis Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Atopic Dermatitis Patient Flow, 2016
Table 2: Global Atopic Dermatitis Patient Flow Forecast, 2016 - 2025
Table 3: Atopic Dermatitis Patient Flow in the US, 2016
Table 4: Atopic Dermatitis Patient Flow Forecast in the US, 2016 - 2025
Table 5: Atopic Dermatitis Patient Flow in Europe, 2016
Table 6: Atopic Dermatitis Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Atopic Dermatitis Patient Flow in Germany, 2016
Table 8: Atopic Dermatitis Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Atopic Dermatitis Patient Flow in France, 2016
Table 10: Atopic Dermatitis Patient Flow Forecast in France, 2016 - 2025
Table 11: Atopic Dermatitis Patient Flow in Spain, 2016
Table 12: Atopic Dermatitis Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Atopic Dermatitis Patient Flow in Italy, 2016
Table 14: Atopic Dermatitis Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Atopic Dermatitis Patient Flow in UK, 2016
Table 16: Atopic Dermatitis Patient Flow Forecast in UK, 2016 - 2025
Table 17: Atopic Dermatitis Patient Flow in Japan, 2016
Table 18: Atopic Dermatitis Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Atopic Dermatitis Patient Flow, 2016
Figure 2: Global Atopic Dermatitis Patient Flow Forecast, 2016 - 2025
Figure 3: Atopic Dermatitis Patient Flow in the US, 2016
Figure 4: Atopic Dermatitis Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Atopic Dermatitis Patient Flow in Europe, 2016
Figure 6: Atopic Dermatitis Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Atopic Dermatitis Patient Flow in Germany, 2016
Figure 8: Atopic Dermatitis Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Atopic Dermatitis Patient Flow in France, 2016
Figure 10: Atopic Dermatitis Patient Flow Forecast in France, 2016 - 2025
Figure 11: Atopic Dermatitis Patient Flow in Spain, 2016
Figure 12: Atopic Dermatitis Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Atopic Dermatitis Patient Flow in Italy, 2016
Figure 14: Atopic Dermatitis Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Atopic Dermatitis Patient Flow in UK, 2016
Figure 16: Atopic Dermatitis Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Atopic Dermatitis Patient Flow in Japan, 2016
Figure 18: Atopic Dermatitis Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report